| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to a combination of a partial alpha 7 nicotine receptor agonist and a acetylcholiesterase inhibitor for treating cognitive disorders, differing by the fact that the partial alpha 7 nicotine receptor agonist is (2E)-but-2-endioatom 4-bromphenyl-1,4-diazabicyclo[3.2.2]nonane-4-carboxylate, and the acetylcholiesterase inhibitor is specified in rivastigmine and donepezil, to a pharmaceutical composition, to a set comprising the combination according to the invention and to using it in treating the cognitive disorders.EFFECT: what is shown is a better effect of the combination on the pro-cognitive pharmacological effect scale as compared to the effect provided by both active substances taken separately.7 cl, 5 dwg |
